WASHINGTON--(BUSINESS WIRE)--Today, the Biotechnology Innovation Organization (BIO) applauds the House of Representatives for passing H.R. 4015, the Corporate Governance Reform and Transparency Act. This bipartisan bill, sponsored by Reps. Sean Duffy (R-WI) and Gregory Meeks (D-NY), was approved by a 238-182 vote.
H.R. 4015 would provide for oversight by the Securities and Exchange Commission (SEC) of proxy advisory firms, ensuring that they operate within appropriate boundaries and are accountable to regulators and the public.
The following statement may be attributed to BIO President and CEO Jim Greenwood:
“By enhancing transparency at proxy advisory firms, this legislation would improve the quality of information available to shareholders as they consider their views on public companies’ corporate governance policies. Proxy votes are the primary means of shareholder engagement with company management, and this bill would ensure that the proxy process is working well for both investors and issuers.
“By requiring proxy advisory firms to minimize conflicts of interest and enhance issuer dialogue, H.R. 4015 would improve the quality of the recommendations disseminated to shareholders and ensure that breakthrough innovation remains at the forefront of company decision-making.
“BIO thanks Representatives Duffy and Meeks for their leadership on this important issue.”
About BIO
BIO is the world's largest trade association representing biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world. BIOtechNOW is BIO's blog chronicling “innovations transforming our world” and the BIO Newsletter is the organization’s bi-weekly email newsletter. Subscribe to the BIO Newsletter.
Upcoming BIO Events
BIO One-on-One Partnering™ @ JPM January 7-11, 2018 San Francisco
BIO Asia International Conference March 19-20, 2018 Tokyo, Japan |
BIO
CEO & Investor Conference
Boston, MA |